Safety and efficacy of SGLT2 inhibitors in diabetic and non-diabetic heart failure patients, a meta-analysis of randomized controlled trials

Category Systematic review
Conference43rd European Society of Cardiology Congress, ESC 2022
Year 2022
This article has no abstract
Epistemonikos ID: 3e07c59dd6bd54d0b941092808a381a657055310
First added on: Feb 15, 2025